InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Friday, 12/19/2014 11:27:46 AM

Friday, December 19, 2014 11:27:46 AM

Post# of 380443
TMED .067,+17.5%,Ihub still dosn't knows about here:

solid.cash almost doubled up to $1.3m. TMED has 53 Employees.

Revenue Per Share (ttm): 0.29,Price/Sales (ttm): 0.40
Price/Book (mrq): 0.59

Total Cash (mrq): 1.33M

rev. Slightly decreased but cash almost doubled. $4.4m in Assets vs 660k debt trading 1m cap. only 18m O/S.there is no Excuse trading less than current MV,Especially when Net assets alone almost 4 times cap.add cash and you end up with 50 cents+ PPS.imo

http://www.otcmarkets.com/stock/TMED/profile

International Distributors &
Manufacturer's Representatives

http://www.trimedyne.com/intersale.htm

Trimedyne, Inc. is a publicly-held, ISO 13485 Certified manufacturer of lasers and disposable fiber-optic delivery devices cleared for sale by the FDA for use in a variety of minimally-invasive surgical applications, including, urology, lithotripsy, orthopedics, spine, arthroscopy, ENT surgery, gynecology, GI surgery, and general surgery.

Trimedyne's lasers and minimally-invasive, patented, single use, side firing fiber-optic devices are used in urology to treat enlarged prostates, and its single use and reusable optical fibers are used to fragment urinary stones in the kidneys, ureter or bladder. Trimedyne's lasers and minimally-invasive, patented, single use, side firing laser needles are also used to treat herniated or ruptured discs in the spine, typically in outpatient procedures.

Trimedyne's lasers and proprietary, fiber-optic laser energy delivery devices are designed to reduce the bleeding and trauma of conventional surgery, reduce or eliminate hospital stays and shorten recuperation time. Trimedyne also owns a broad portfolio of U.S. Patents covering lasers and fiber-optic laser energy delivery devices.

Trimedyne leases a modern 28,000 sq. ft. office and manufacturing facility in Lake Forest, California.

Trimedyne's wholly-owned subsidiary, Mobile Surgical Technologies, Inc. ("MST") is a "fee per case" provider of lasers, laser operators, and fiber-optic laser energy delivery devices to hospitals, outpatient surgery centers and physicians in Texas and adjoining states, enabling them to avoid buying a laser and hiring and training a technician to operate it. MST is based in Dallas, Texas.

http://www.otcmarkets.com/stock/TMED/profile

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.